Randox STI assay gets CE mark
March 6, 2020—Randox announced that its Randox STI assay has received the CE mark. The multiplex assay detects 10 STIs, including co-infections, from a single patient sample.
Webinars and Sponsored Roundtables — Register Now
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Industry News
Thermo Fisher to acquire Qiagen
March 5, 2020—Thermo Fisher Scientific will acquire Qiagen, the companies announced on March 3.
FDA issues policy to expedite availability of COVID-19 dx
March 4, 2020—The FDA issued on Feb. 29 a new policy for certain laboratories seeking to develop diagnostic tests for coronavirus in order to achieve more rapid testing capacity in the U.S.
EmPath Smart Camera debuts at USCAP
March 3, 2020—Singularity.ai, a new company delivering integrated workflow solutions for physicians, released its first product, the EmPath Smart Camera, an AI-enabled box top that is used with a microscope.
EDX respiratory panel control
March 2, 2020—Exact Diagnostics, which Bio-Rad acquired in 2019, launched EDX RP Positive Run Control, an unassayed external quality control intended to monitor the performance of clinical respiratory assays.
Ortho Clinical launches Vitros XT 3400 chemistry system
Feb. 28, 2020—Ortho Clinical Diagnostics launched the Vitros XT 3400 chemistry system, completing the suite of the company’s Vitros XT Solutions, which includes the Vitros XT 7600 integrated system and new XT MicroSlides.
Qiagen ships QIAstat-Dx test kits for SARS-CoV-2
Feb. 27, 2020—Qiagen announced it has shipped its newly developed QIAstat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation and is in the process of shipping QIAstat-Dx testing kits to public health institutions in other regions, including Europe, Southeast Asia, and the Middle East.
Thermo Fisher introduces kit for expanded carrier screening
Feb. 27, 2020—Thermo Fisher Scientific introduced the Ion Torrent CarrierSeq ECS Kit for the Ion GeneStudio S5 system.
Hologic launches scalable options for Panther
Feb. 26, 2020–Hologic announced that the FDA-approved and CE-marked Panther Plus and Panther Link are available in the U.S. and Europe.
Quest selects Siemens Atellica for IA testing
Feb. 25, 2020—Siemens Healthineers announced that it was selected by Quest Diagnostics to be its preferred supplier for immunoassay testing.